Search:
Advanced Search
ATVB Home
Subscriptions
Archives
Feedback
Authors
Help
AHA Journals Home
« Previous Issue
|
Next Issue »
About This Cover
Volume 28, Issue 4; April 1, 2008
Editorials
Brief Reviews
Integrative Physiology/Experimental Medicine
Cell Biology/Signaling
Letters to the Editor
Corrections
Clinical and Population Studies
Search This Issue:
Table of Contents (PDF)
Index by Author
Sign up for eTOCs
To see an article, click its "Full Text" or "PDF" link. To review many abstracts, check the boxes to the left of the titles you want, and click the "Get All Checked Abstract(s)" button. To see one abstract at a time, click its "Abstract" link.
article is free immediately upon publication
Editorials
Does Tissue Factor Expression by Vascular Smooth Muscle Cells Provide a Link Between C-Reactive Protein and Cardiovascular Disease?
Nigel Mackman and Mark B. Taubman
Arterioscler Thromb Vasc Biol. 2008;28:601-603, doi:10.1161/ATVBAHA.108.165050
Full Text
|
PDF
VEGFR1 for Lymphangiogenesis: An Alternative Signaling Pathway?
Yasufumi Sato
Arterioscler Thromb Vasc Biol. 2008;28:604-605, doi:10.1161/ATVBAHA.108.162032
Full Text
|
PDF
Vascular Calcification in Homozygote Familial Hypercholesterolemia
Joel D. Morrisett and Kasey C. Vickers
Arterioscler Thromb Vasc Biol. 2008;28:606-607, doi:10.1161/ATVBAHA.108.163378
Full Text
|
PDF
More Sugar, Less Blood Vessels: Another Piece in the Puzzle of Increased Cardiovascular Risk in Diabetes
Christian Rask-Madsen and George L. King
Arterioscler Thromb Vasc Biol. 2008;28:608-610, doi:10.1161/ATVBAHA.108.162057
Full Text
|
PDF
Serum or Plasma Samples?: The "Cinderella" Role of Blood Collection Procedures Preanalytical Methodological Issues Influence the Release and Activity of Circulating Matrix Metalloproteinases and Their Tissue Inhibitors, Hampering Diagnostic Trueness and Leading to Misinterpretation
Ferdinando Mannello
Arterioscler Thromb Vasc Biol. 2008;28:611-614, doi:10.1161/ATVBAHA.107.159608
Full Text
|
PDF
Brief Reviews
CD47: A New Target in Cardiovascular Therapy
Jeff S. Isenberg, David D. Roberts, and William A. Frazier
Arterioscler Thromb Vasc Biol. 2008;28:615-621; published online before print January 10 2008, doi:10.1161/ATVBAHA.107.158154
Abstract
|
Full Text
|
PDF
Final Common Molecular Pathways of Aging and Cardiovascular Disease: Role of the p66
Shc
Protein
Francesco Cosentino, Pietro Francia, Giovanni G. Camici, Pier Giuseppe Pelicci, Massimo Volpe, and Thomas F. Lüscher
Arterioscler Thromb Vasc Biol. 2008;28:622-628; published online before print December 27 2007, doi:10.1161/ATVBAHA.107.156059
Abstract
|
Full Text
|
PDF
Mice carrying a targeted mutation of the p66Shc gene display reduced production of intracellular oxidants, increased resistance to oxidative stress-induced apoptosis, prolonged lifespan, and are protected against vascular, cardiac, and renal impairment attributable to hypercholesterolemia, aging, diabetes, and ischemia/reperfusion. The present review focuses on the biochemical function of the p66Shc adaptor protein as well as on the mechanisms linking p66Shc to the pathophysiology of aging and cardiovascular disease.
Metabolic Syndrome Pandemic
Scott M. Grundy
Arterioscler Thromb Vasc Biol. 2008;28:629-636; published online before print January 3 2008, doi:10.1161/ATVBAHA.107.151092
Abstract
|
Full Text
|
PDF
|
Additional Materials
The metabolic syndrome represents a clustering of metabolic risk factors for cardiovascular disease. The available evidence indicates that in most countries between 20% and 30% of the adult population has the metabolic syndrome. Because of this relatively high prevalence, the metabolic syndrome accounts for an increasing proportion of cardiovascular risk worldwide.
Integrative Physiology/Experimental Medicine
Therapeutic Angiogenesis Using Tissue Engineered Human Smooth Muscle Cell Sheets
Kyoko Hobo, Tatsuya Shimizu, Hidekazu Sekine, Toshiharu Shinoka, Teruo Okano, and Hiromi Kurosawa
Arterioscler Thromb Vasc Biol. 2008;28:637-643; published online before print January 17 2008, doi:10.1161/ATVBAHA.107.151829
Abstract
|
Full Text
|
PDF
|
Additional Materials
We developed tissue engineered cell sheets which can be transplanted en bloc to provide a stable and localizable biological effect in ischemic tissue. Smooth muscle cell sheets transplantation result in significantly enhanced angiogenesis and blood perfusion through the secretion of angiogenic factors and integration with newly formed vessels.
Ex Vivo Priming of Endothelial Progenitor Cells With SDF-1 Before Transplantation Could Increase Their Proangiogenic Potential
Faouzia Zemani, Jean-Sébastien Silvestre, Françoise Fauvel-Lafeve, Arlette Bruel, José Vilar, Ivan Bieche, Ingrid Laurendeau, Isabelle Galy-Fauroux, Anne Marie Fischer, and Catherine Boisson-Vidal
Arterioscler Thromb Vasc Biol. 2008;28:644-650; published online before print January 31 2008, doi:10.1161/ATVBAHA.107.160044
Abstract
|
Full Text
|
PDF
|
Additional Materials
EPC exposure to SDF-1 for 30 min induced a proangiogenic phenotype, enhancing not only the ability of these cells to adhere to activated endothelium but also promoting tube formation, via integrin-, CXCR4-, and HSPGs-dependent mechanisms. Subsequently, SDF-1-treated EPCs displayed a marked therapeutic potential in a model of mice hindlimb ischemia.
Protein Modification by O-Linked GlcNAc Reduces Angiogenesis by Inhibiting Akt Activity in Endothelial Cells
Bai Luo, Yudi Soesanto, and Donald A. McClain
Arterioscler Thromb Vasc Biol. 2008;28:651-657; published online before print January 3 2008, doi:10.1161/ATVBAHA.107.159533
Abstract
|
Full Text
|
PDF
|
Additional Materials
Angiogenesis is impaired in diabetes. Here, we demonstrate that elevated O-GlcNAc levels inhibit vascular sprouting from mouse aortic rings and migration and capillary-like structure formation of endothelial cells. Akt signaling plays a key role in this O-GlcNAc-mediated angiogenesis regulation.
VEGFR1 Tyrosine Kinase Signaling Promotes Lymphangiogenesis as Well as Angiogenesis Indirectly via Macrophage Recruitment
Masato Murakami, Yujuan Zheng, Masanori Hirashima, Toshio Suda, Yohei Morita, Jun Ooehara, Hideo Ema, Guo-Hua Fong, and Masabumi Shibuya
Arterioscler Thromb Vasc Biol. 2008;28:658-664; published online before print January 3 2008, doi:10.1161/ATVBAHA.107.150433
Abstract
|
Full Text
|
PDF
|
Additional Materials
Vegf-A transgenic (Tg) mice show not only angiogenesis but also lymphangiogenesis. To examine how important the tyrosine kinase (TK) of VEGFR1 in lymphangiogenesis, we crossed them with VEGFR1-TK-deficient mice. Double mutant mice demonstrated a remarkable decrease in lymphangiogenesis. We found that VEGFR1-signaling promotes lymphangiogenesis indirectly via macrophage recruitment.
SM16, an Orally Active TGF-β Type I Receptor Inhibitor Prevents Myofibroblast Induction and Vascular Fibrosis in the Rat Carotid Injury Model
Kai Fu, Michael J. Corbley, Lihong Sun, Jessica E. Friedman, Feng Shan, James L. Papadatos, Donald Costa, Frank Lutterodt, Harry Sweigard, Scott Bowes, Michael Choi, P. Ann Boriack-Sjodin, Robert M. Arduini, Dongyu Sun, Miki N. Newman, Xiamei Zhang, Jonathan N. Mead, Claudio E. Chuaqui, H. -Kam Cheung, Xin Zhang, Mark Cornebise, Mary Beth Carter, Serene Josiah, Juswinder Singh, Wen-Cherng Lee, Alan Gill, and Leona E. Ling
Arterioscler Thromb Vasc Biol. 2008;28:665-671; published online before print January 17 2008, doi:10.1161/ATVBAHA.107.158030
Abstract
|
Full Text
|
PDF
|
Additional Materials
Inhibition of Plasminogen Activator Inhibitor-1: Its Mechanism and Effectiveness on Coagulation and Fibrosis
Yuko Izuhara, Satoru Takahashi, Masaomi Nangaku, Shunya Takizawa, Hideyuki Ishida, Kiyoshi Kurokawa, Charles van Ypersele de Strihou, Noriaki Hirayama, and Toshio Miyata
Arterioscler Thromb Vasc Biol. 2008;28:672-677; published online before print January 31 2008, doi:10.1161/ATVBAHA.107.157479
Abstract
|
Full Text
|
PDF
|
Additional Materials
We identify novel orally active molecules able to enter, as a mock compound, into the strand 4 position (s4A) of the A β-sheet in plasminogen activator inhibitor (PAI)-1. In vitro they specifically inhibit the PAI-1 activity. In vivo, the most efficient molecule (TM5007) inhibits coagulation and prevents the fibrotic process.
Role for Staphylococci in Misguided Thrombus Resolution of Chronic Thromboembolic Pulmonary Hypertension
Diana Bonderman, Johannes Jakowitsch, Bassam Redwan, Helga Bergmeister, Maria-Klara Renner, Heidi Panzenböck, Christopher Adlbrecht, Apostolos Georgopoulos, Walter Klepetko, Meinhard Kneussl, and Irene M. Lang
Arterioscler Thromb Vasc Biol. 2008;28:678-684; published online before print January 31 2008, doi:10.1161/ATVBAHA.107.156000
Abstract
|
Full Text
|
PDF
Mechanisms underlying thrombus persistence in chronic thromboembolic pulmonary hypertension (CTEPH) are unknown. In the present work, we analyzed human surgical CTEPH specimens and experimental murine venous thrombi. Our findings suggest a pivotal role for bacterial infection in the fibrotic organization process and persistence of thrombotic material in CTEPH.
Dietary Cholesterol Worsens Adipose Tissue Macrophage Accumulation and Atherosclerosis in Obese LDL Receptor–Deficient Mice
Savitha Subramanian, Chang Yeop Han, Tsuyoshi Chiba, Timothy S. McMillen, Shari A. Wang, Antonio Haw, III, Elizabeth A. Kirk, Kevin D. OBrien, and Alan Chait
Arterioscler Thromb Vasc Biol. 2008;28:685-691; published online before print January 31 2008, doi:10.1161/ATVBAHA.107.157685
Abstract
|
Full Text
|
PDF
|
Additional Materials
The role of dietary cholesterol has been controversial. Here we show that cholesterol added to a diet rich in saturated fat and carbohydrates increases macrophage accumulation in adipose tissue, worsens insulin resistance, induces a heightened state of chronic inflammation, and increases atherosclerosis in LDLR-/- mice.
Dimethylarginine Dimethylaminohydrolase Overexpression Enhances Insulin Sensitivity
Karsten Sydow, Carl E. Mondon, Joerg Schrader, Hakuoh Konishi, and John P. Cooke
Arterioscler Thromb Vasc Biol. 2008;28:692-697; published online before print January 31 2008, doi:10.1161/ATVBAHA.108.162073
Abstract
|
Full Text
|
PDF
We hypothesized that a reduction in the endogenous NOS inhibitor ADMA by overexpression of the DDAH enzyme would increase NO synthesis and thereby enhance insulin sensitivity. In response to a glucose load, the DDAH transgenic mouse manifested greater insulin sensitivity, mediated in part by enhanced hepatic or skeletal muscle response to insulin. ADMA may be a new target for treatment of insulin resistance.
Cell Biology/Signaling
C-Reactive Protein Enhances Tissue Factor Expression by Vascular Smooth Muscle Cells: Mechanisms and In Vivo Significance
Jianbo Wu, Meredith J. Stevenson, Jordan M. Brown, Elizabeth A. Grunz, Tammy L. Strawn, and William P. Fay
Arterioscler Thromb Vasc Biol. 2008;28:698-704; published online before print February 14 2008, doi:10.1161/ATVBAHA.107.160903
Abstract
|
Full Text
|
PDF
|
Additional Materials
We show that upregulation of C-reactive protein (CRP) expression increases tissue factor (TF) expression while decreasing TF pathway inhibitor expression in vascular smooth muscle cells, both in vitro and in vivo. Induction of TF expression by CRP is mediated by Fc{gamma} receptor IIIa, p44/42 MAP kinase, and reactive oxygen species generation.
Prothrombotic Gene Expression Profile in Vascular Smooth Muscle Cells of Human Saphenous Vein, but Not Internal Mammary Artery
S.K. Payeli, R. Latini, C. Gebhard, A. Patrignani, U. Wagner, T.F. Lüscher, and F.C. Tanner
Arterioscler Thromb Vasc Biol. 2008;28:705-710; published online before print February 7 2008, doi:10.1161/ATVBAHA.107.155333
Abstract
|
Full Text
|
PDF
|
Additional Materials
Expression profiles of coagulation genes were analyzed by Affymetrix microarrays in vascular smooth muscle cells from internal mammary artery (IMA) versus saphenous vein (SV). TF expression was lower in IMA than SV, whereas tPA was higher. This pattern is consistent with protection of IMA from thrombus formation and vascular remodeling.
PARP-1 Inhibition Prevents Oxidative and Nitrosative Stress–Induced Endothelial Cell Death via Transactivation of the VEGF Receptor 2
Marlene T. Mathews and Bradford C. Berk
Arterioscler Thromb Vasc Biol. 2008;28:711-717; published online before print January 31 2008, doi:10.1161/ATVBAHA.107.156406
Abstract
|
Full Text
|
PDF
|
Additional Materials
PARP-1, a DNA repair enzyme activated by oxidative and nitrosative stress, consumes cellular energy and precipitates endothelial cell death. Here we show that PARP-1 inhibition prevents ROS- and RNS-induced HUVEC death not only by maintaining cellular energy, but also through a novel mechanism via VEGFR2, Akt, and Bad phosphorylation.
A New Mechanism Involving ERK Contributes to Rosiglitazone Inhibition of Tumor Necrosis Factor-
and Interferon-
Inflammatory Effects in Human Endothelial Cells
Adriana Lombardi, Giulia Cantini, Elisabetta Piscitelli, Stefania Gelmini, Michela Francalanci, Tommaso Mello, Elisabetta Ceni, Gabriele Varano, Gianni Forti, Mario Rotondi, Andrea Galli, Mario Serio, and Michaela Luconi
Arterioscler Thromb Vasc Biol. 2008;28:718-724; published online before print January 31 2008, doi:10.1161/ATVBAHA.107.160713
Abstract
|
Full Text
|
PDF
|
Additional Materials
We demonstrate that TNF{alpha} and IFN{gamma} proinflammatory effects, such as upregulation of IP10 secretion, fractalkine, and adhesion molecule expression, are partially prevented by RGZ in human microvascular endothelial cells through a novel rapid nongenomic mechanism involving the ability of this molecule to inhibit ERK activation/phosphorylation.
Cross Talk Among Smad, MAPK, and Integrin Signaling Pathways Enhances Adventitial Fibroblast Functions Activated by Transforming Growth Factor–β1 and Inhibited by Gax
Ping Liu, Cheng Zhang, Jin Bo Feng, Yu Xia Zhao, Xu Ping Wang, Jian Min Yang, Ming Xiang Zhang, Xing Li Wang, and Yun Zhang
Arterioscler Thromb Vasc Biol. 2008;28:725-731; published online before print January 10 2008, doi:10.1161/ATVBAHA.107.159889
Abstract
|
Full Text
|
PDF
|
Additional Materials
We investigated whether Smad, MAPK, and integrin signaling pathways cross-talk to enhance adventitial fibroblast (AF) bioactivity activated by TGF-β1. We found Gax counteracted TGF-β1 effects, blocked the cross-talk of these pathways, and inhibited AF functions. Thus, Gax is a promising therapeutic gene for dissecting the signaling pathways controlling AF bioactivities.
Suppressing PTEN Activity by Tobacco Smoke Plus Interleukin-1β Modulates Dissociation of VE-Cadherin/β-Catenin Complexes in Endothelium
Silvia S. Barbieri, Luca Ruggiero, Elena Tremoli, and Babette B. Weksler
Arterioscler Thromb Vasc Biol. 2008;28:732-738; published online before print January 17 2008, doi:10.1161/ATVBAHA.107.159434
Abstract
|
Full Text
|
PDF
|
Additional Materials
Tobacco smoke (TS) cooperates with interleukin-1β to accelerate and enhance endothelial dysfunction. Our study shows that PTEN deactivation induced by TS plus IL-1β modulates tyrosine phosphorylation and destabilizes VE-cadherin/β-catenin complexes. Therefore, pharmacological inhibitors of PTEN-deactivation may represent potential therapeutic tools to prevent endothelial-related vascular disorders.
Far Infrared Therapy Inhibits Vascular Endothelial Inflammation via the Induction of Heme Oxygenase-1
Chih-Ching Lin, Xiao-Ming Liu, Kelly Peyton, Hong Wang, Wu-Chang Yang, Shing-Jong Lin, and William Durante
Arterioscler Thromb Vasc Biol. 2008;28:739-745; published online before print January 17 2008, doi:10.1161/ATVBAHA.107.160085
Abstract
|
Full Text
|
PDF
|
Additional Materials
Far infrared (FIR) therapy improves survival of arteriovenous fistulas in hemodialysis patients, but the underlying mechanism is unknown. We now report that FIR radiation stimulates heme oxygenase-1 (HO-1) expression in endothelial cell and that the induction of HO-1 confers antiinflammatory actions that may underlie the beneficial effects of FIR therapy.
High Glucose Enhances Transient Receptor Potential Channel Canonical Type 6–Dependent Calcium Influx in Human Platelets via Phosphatidylinositol 3-Kinase–Dependent Pathway
Daoyan Liu, Alexandra Maier, Alexandra Scholze, Ursula Rauch, Ulrike Boltzen, Zhigang Zhao, Zhiming Zhu, and Martin Tepel
Arterioscler Thromb Vasc Biol. 2008;28:746-751; published online before print February 7 2008, doi:10.1161/ATVBAHA.108.162222
Abstract
|
Full Text
|
PDF
We tested the hypothesis that hyperglycemia increases transient receptor potential canonical type 6 (TRPC6) channel expression and 1-oleoyl-2-acetyl-sn-glycerol (OAG)-induced calcium entry in human platelets. Glucose significantly enhanced the OAG-induced calcium influx and TRPC6 expression, which was attenuated by inhibitors of the phosphatidylinositol 3-kinase, wortmannin or LY294002.
Letters to the Editor
Reactive Hyperemia Revisited
Daniela Calderaro, Maristela C. Monachini, Carolina L.Z. Vieira, Pai Ching Yu, Danielle M. Gualandro, Andre C. Marques, and Bruno Caramelli
Arterioscler Thromb Vasc Biol. 2008;28:e23-e24, doi:10.1161/ATVBAHA.107.158931
Full Text
|
PDF
Reactive Hyperemia Revisited
Alex L. Huang and Joseph A. Vita
Arterioscler Thromb Vasc Biol. 2008;28:e25, doi:10.1161/ATVBAHA.107.159525
Full Text
|
PDF
Is Serum Gamma-Glutamyltransferase a Biomarker of Xenobiotics, Which Are Conjugated by Glutathione?
Duk-Hee Lee, Myron D. Gross, Michael W. Steffes, and David R. Jacobs, Jr
Arterioscler Thromb Vasc Biol. 2008;28:e26-e28, doi:10.1161/ATVBAHA.107.159376
Full Text
|
PDF
Is Serum-Glutamylatransferase a Biomarker of Xenobiotics Which Are Conjugated by Glutathione?
A. Fraser, N. Sattar, S. Ebrahim, and D.A. Lawlor
Arterioscler Thromb Vasc Biol. 2008;28:e29, doi:10.1161/ATVBAHA.107.161299
Full Text
|
PDF
Corrections
Correction
Arterioscler Thromb Vasc Biol. 2008;28:e30, doi:10.1161/ATVBAHA.108.154864
Full Text
|
PDF
Clinical and Population Studies
C242T Polymorphism of NADPH Oxidase p22phox and Recurrence of Cardiovascular Events in Coronary Artery Disease
Marcello Arca, Beatrice Conti, Anna Montali, Pasquale Pignatelli, Filomena Campagna, Francesco Barillà, Gaetano Tanzilli, Roberto Verna, Annarita Vestri, Carlo Gaudio, and Francesco Violi
Arterioscler Thromb Vasc Biol. 2008;28:752-757; published online before print January 31 2008, doi:10.1161/ATVBAHA.107.154823
Abstract
|
Full Text
|
PDF
|
Additional Materials
The C242T SNP in the p22phox gene was evaluated in 213 coronary patients during a median 7.8-year follow-up; the occurrence of cardiovascular events was lower in CT/TT than in CC carriers. These data suggest a role for oxidative stress in the recurrence of cardiovascular events in coronary patients.
Fibrinogen Genes and Myocardial Infarction: A Haplotype Analysis
Werner Koch, Petra Hoppmann, Janita Biele, Jakob C. Mueller, Albert Schömig, and Adnan Kastrati
Arterioscler Thromb Vasc Biol. 2008;28:758-763; published online before print January 17 2008, doi:10.1161/ATVBAHA.107.157842
Abstract
|
Full Text
|
PDF
|
Additional Materials
There is no clear evidence for a role of variations in the genes coding for the fibrinogen-{alpha}, fibrinogen-β, and fibrinogen-{gamma} polypeptide chains in atherosclerotic diseases. We examined 2 large case-control samples and found that haplotypes based on single nucleotide polymorphisms in the fibrinogen gene region on chromosome 4 were not associated with myocardial infarction.
Angiotensin II Type 1 Receptor 1166C Polymorphism Is Associated With Abdominal Aortic Aneurysm in Three Independent Cohorts
Gregory T. Jones, Andrew R. Thompson, Frank M. van Bockxmeer, Hany Hafez, Jackie A. Cooper, Jonathan Golledge, Stephen E. Humphries, Paul E. Norman, and Andre M. van Rij
Arterioscler Thromb Vasc Biol. 2008;28:764-770; published online before print January 31 2008, doi:10.1161/ATVBAHA.107.155564
Abstract
|
Full Text
|
PDF
This study examined common genetic variants of the renin angiotensin system previously associated with susceptibility to atherosclerosis to determine whether they play any role in AAA susceptibility. A strong and repeated association between the AGTR1 1166C allele and susceptibility to AAA was identified in 3 geographically distinct case-control cohorts.
Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1) Polymorphism and Aortic Calcification: The Rotterdam Study
M. Teichert, L.E. Visser, R.H.N. van Schaik, A. Hofman, A.G. Uitterlinden, P.A.G. M. De Smet, J.C.M. Witteman, and B.H.Ch. Stricker
Arterioscler Thromb Vasc Biol. 2008;28:771-776; published online before print January 24 2008, doi:10.1161/ATVBAHA.107.159913
Abstract
|
Full Text
|
PDF
Besides effects on hemostasis, vitamin K-dependent proteins play a role in bone mineralization and arterial calcification. We investigated the association between the VKORC1 1173C>T polymorphism and calcification of the aortic far wall in Whites. The T-allele of this polymorphism was significantly associated with a higher risk of aortic calcification.
Vascular Calcifications in Homozygote Familial Hypercholesterolemia
Z. Awan, K. Alrasadi, G.A. Francis, R.A. Hegele, R. McPherson, J. Frohlich, D. Valenti, B. de Varennes, M. Marcil, C. Gagne, J. Genest, and P. Couture
Arterioscler Thromb Vasc Biol. 2008;28:777-785; published online before print January 31 2008, doi:10.1161/ATVBAHA.107.160408
Abstract
|
Full Text
|
PDF
|
Additional Materials
We examined 25 patients (mean age 32 years; range 5 to 54) with homozygous familial hypercholesterolemia. Baseline cholesterol was 19{+/-}5 mmol/L (737{+/-}206 mg/dL). We documented premature severe aortic calcifications quantified using computed tomography (CT) in all adult hmzFH patients studied. An elevated mean calcium score was found in patients by age 20.
Plasminogen Activator Inhibitor-1 Activity in Type 2 Diabetes: A Different Relationship With Coronary Heart Disease and Diabetic Retinopathy
Laima Brazionis, Kevin Rowley, Alicia Jenkins, Catherine Itsiopoulos, and Kerin ODea
Arterioscler Thromb Vasc Biol. 2008;28:786-791; published online before print January 31 2008, doi:10.1161/ATVBAHA.107.160168
Abstract
|
Full Text
|
PDF
Leukocyte Activation by Triglyceride-Rich Lipoproteins
Arash Alipour, Antonie J.H. H.M van Oostrom, Alisa Izraeljan, Caroline Verseyden, Jennifer M. Collins, Keith N. Frayn, Thijs W.M. Plokker, Jan Willem F. Elte, and Manuel Castro Cabezas
Arterioscler Thromb Vasc Biol. 2008;28:792-797; published online before print January 24 2008, doi:10.1161/ATVBAHA.107.159749
Abstract
|
Full Text
|
PDF
|
Additional Materials
Leukocyte activation by TRLs by membrane-associated CD11b and CD66b was shown. Uptake of meal-derived fatty acids by leukocytes and apoB binding on neutrophils and monocytes was also demonstrated. Hypertriglyceridemia is a leukocyte activator most likely by binding of TRLs to leukocytes and uptake of dietary fatty acids.
Spotlight
TOC Spotlight File
Advertisement
ATVB Home
|
Subscriptions
|
Archives
|
Feedback
|
Authors
|
Help
|
AHA Journals Home
|
Search
Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.